CORAL GABLES, FL / ACCESSWIRE / January 2, 2019 / This past year has been wild for the stock market, but now that we're a few days into the new year, possibilities in the space are endless. As sectors across all industries try and start off the year as strong as possible, this week's investors are being presented with several stocks providing volatile upswings just after the new year. As we move, headfirst into the new year, Premier Health Group (OTC:PHGRF) (CSE:PHGI), Prana Biotechnology Limited (NASDAQ: PRAN), Safe-T Group Ltd (NASDAQ: SFET), and vTv Therapeutics Inc (NASDAQ: VTVT) are presenting investors with potential opportunities just after the break of the new year.
Premier Health Group (OTC:PHGRF) (CSE:PHGI) enjoyed a strong month of bullish trading in December, following momentum gained from several announcements regarding strategic plans for growth set in place, that have provided investors in the healthcare industry with excitement. Shares of the Company gained over 30% during the month of December, with shares closing at $0.66 per share at the end of trading on Monday.
In recent news, Premier Health Group (OTC:PHGRF) (CSE:PHGI) has been largely focusing its efforts on developing and implementing a strategic growth model with announcements that continue to build interest. In early December, the Company announced it had signed a binding Letter of Intent agreement to acquire all outstanding securities of Cloud Practice Inc. According to the announcement, Premier will acquire key products from Cloud's portfolio, including Juno EMR, a cloud-based EMR solution which is currently used by 287 clinics, over 3,000 licensed practitioners, 1,500 staff and 2.8 million registered patients.
In addition to their announcement regarding Cloud Practice, the Company signed another binding LOI to acquire a Vancouver-based pharmacy.
Dr. EssamHamza , CEO of Premier Health, said: "We are ecstatic at the opportunity to build on our patient-centric technology platform through the integration of Cloud Practice's suite of software solutions. They have a strong team of developers who are just as enthusiastic as we are about the future of healthcare. We believe that this partnership will help facilitate our vision of integrating telemedicine, online booking, and other premium services with our electronic medical record (EMR) system."
Prana Biotechnology Limited (PRAN) announced, early last week, that it had entered into a securities purchase agreement for a lead investment by Boston based Life Biosciences LLC to raise up to approximately $31.4 million. Life Biosciences will initially invest $7.5 million, with the agreement allowing Prana to raise an additional $2 million from other investors, totaling $9.5 million.
In a press release regarding the matter, Prana Chairman and CEO, Geoffrey Kempler said,"Life Biosciences' investment in Prana is an important endorsement of the significance of our work in addressingneurodegenerative disease. This financing will potentially allow us to accelerate our drug development programs."
Safe-T Group, Ltd (SFET), a leading provider of software-defined access solutions for cloud computing, announced on Monday that one of its systems integrators received an order from the largest Israeli beverage company. According to the announcement, the ordered system is an extension of a system currently used by the beverage company, which integrates the Company's SDE and SDA solutions for secure sharing of information through several methods.
Shahar Daniel, CEO of Safe-T, commented: "This is a strategic order for us. The beverage company is a longtime customer of ours, and they have now decided to use our innovative solutions to more deeply protect their systems. The ordered SDA solution aims to significantly reduce the organization's exposure to attacks, without compromising remote access to its internal applications."
vTv Therapeutics Inc (VTVT) announced, in early November, all associated achievements relevant to the Company in itsthird quarter earnings report.
In a press release regarding the announcement, Steve Holcombe, chief executive officer, vTv Therapeutics commented: ''We continue to believe in the therapeutic potential ofazeliragon and are committed to finding the optimal development pathway forward for the program. We are also making progress with our other programs, either internally in the case of our GKA program, or through our licensing partners for our GLP-1R agonist, PPAR-delta, and PDE4 programs. We hope to see milestones achieved for each of these programs during 2019.''
What Is Stock Price (StockPrice.com)?
Stock Price is defined as the price of a single share of a number of saleable stocks of a public company. A stock price is the highest amount an investor or trader is willing to pay for the stock, or the lowest amount that it can be bought for.
StockPrice.com was created for everyone that wants the latest stock quotes, stock charts, company news, and the best financial content.
At Stock Price (StockPrice.com), you get free stock quotes, up-to-date news, international market data, social interaction and the best financial content that will help you manage your financial life.
Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. JSG Communications, LLC which owns www.StockPrice.com is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release.
JSG Communications, LLC, which owns www.StockPrice.com, may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice. JSG Communications, LLC, which owns www.StockPrice.com, may be compensated for its services in the form of cash-based compensation or equity securities in the companies it writes about, or a combination of the two.
Pursuant to an agreement between MIDAM VENTURES, LLC an affiliate of JSG COMMUNICATIONS LLC and Premier Health Group Inc. we were hired for a period from 10/1/2018 – 4/1/2019 to publicly disseminate information about Premier Health Group Inc. including on the Website and other media including Facebook and Twitter. We were paid $300,000 (CASH) for & were paid "500,000" shares of restricted common shares (as of 1/2/2019). We own zero shares of Premier Health Group Inc., which we purchased in the open market. Once the (6) Six-month restriction is complete on 4/1/2019 we plan to sell the "500,000" shares of Premier Health Group Inc. that we hold currently in restricted form during the time the Website and/or Facebook and Twitter Information recommends that investors or visitors to the website purchase without further notice to you. We may buy or sell additional shares of Premier Health Group Inc. in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information Please click here for full disclaimer.